Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Expedition Therapeutics Raises $165M Series A Led by Sofinnova Investments and Novo Holdings
Series AVenture Capital

Expedition Therapeutics Raises $165M Series A Led by Sofinnova Investments and Novo Holdings

•October 10, 2025
•Oct 10, 2025
0

Participants

Expedition Therapeutics

Expedition Therapeutics

company

Novo Holdings

Novo Holdings

investor

Ad Age

Ad Age

investor

BAM

BAM

investor

Forbion

Forbion

investor

Sofinnova

Sofinnova

investor

Dawn Bio

Dawn Bio

investor

Sanofi Ventures

Sanofi Ventures

investor

Molecular Partners

Molecular Partners

investor

Deal Summary

Expedition Therapeutics, a San Francisco biotech developing therapies for inflammatory and respiratory diseases, raised $165M in a Series A round led by Sofinnova Investments and Novo Holdings. Additional investors include Forbion, Dawn Biopharma (KKR), Adage, Balyasny, Logos Capital, Sanofi Ventures and BVF Partners.

0

Comments

Want to join the conversation?

Loading comments...